Background: Ginsenoside Rg1 (Rg1) is believed to be one of the main active principles in ginseng, a traditional Chinese medicine extensively used to enhance stamina and deal with fatigue as well as physical stress. It has been reported that Rg1 performs multiple biological activities, including neuroprotective activity. In this study, we investigated the efficacy of ginsenoside Rg1 on ischemiaereperfusion injury in cultured hippocampal cells and also probed its possible mechanisms. Methods: To establish a model of oxygeneglucose deprivation (OGD) and reperfusion, cultured hippocampal neurons were exposed to OGD for 2.5 hours, followed by a 24-hour reoxygenation. Cultured hippocampal neurons were randomly divided into control group, model group (vehicle), and ginsenoside Rg1 treatment groups (5mM, 20mM, 60mM). At 24 hours post-OGD, the intracellular free calcium concentration was detected using Furo-3/AM-loaded hippocampal neurons deprived of oxygen and glucose. Neuronal nitric oxide synthase (nNOS) activity was measured by chemical colorimetry. Cell apoptosis was evaluated by Hoechst staining, and the neuron viability was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Results: Excitotoxic neuronal injury of OGD was demonstrated by the increase of intracellular free calcium concentrations and elevated nNOS activity in the model group compared with the control group. The intracellular free calcium concentrations and the nNOS activity in the groups receiving intermediate and high dose of ginsenoside Rg1 were significantly lower than those of the control group (p < 0.05). In addition, intermediate and high dose of ginsenoside Rg1 administration could also attenuate the cell viability loss (p < 0.05) and cell apoptosis induced by OGD. Conclusion: Ginsenoside Rg1 has neuroprotective effect on ischemiaereperfusion injury in cultured hippocampal cells mediated by blocking calcium over-influx into neuronal cells and decreasing the nNOS activity after OGD exposure. We infer that ginsenoside Rg1 may serve as a potential therapeutic agent for cerebral ischemia injury.
Introduction
Ischemic cerebral stroke is a devastating event that has become the third greatest cause of mortality and the leading cause of disability worldwide, and results in many serious physical, psychological, and social difficulties. However, the treatment of stroke still remains highly unsatisfactory. A variety of clinical trials of pharmacological neuroprotective strategies in stroke have been demonstrated to be disappointing. 1 Therefore, seeking new neuroprotective agents for cerebral stroke management in order to improve clinical prognoses in patients with brain ischemic injury is urgent.
Ginseng, the root of Panax ginseng C.A. Meyer (Araliaceae), a well-known traditional Chinese medicine, has been widely used to enhance stamina and deal with fatigue as well as physical stress for thousands of years in oriental countries. 2 Ginsenosides, or ginseng saponins, are widely considered to among the principal bioactive constituents of ginseng, and provide diverse benefits due to their structural isomerism and stereoisomerism. 3 Up to now, over 30 different ginsenosides have been isolated and identified from ginseng, and they are classified into two major groups: protopanaxadiol and protopanaxatriol saponins, according to their chemical structures. 3 Recently, the effects of different kinds of ginsenosides have been extensively studied, and a great spectrum of pharmacological responses has been reported, including effects on the central nervous system, cardiovascular system, endocrine system, immune system, and cancer. 3, 4 Neuronal cell damage, including apoptosis, is the principal event occurring in the acute and subacute phases of cerebral ischemia. Ginsenoside Rg1 (Fig. 1) , 5 belonging to the protopanaxatriol group, is an important active component of ginseng. The neuroprotective effects of ginsenoside Rg1 have been extensively investigated recently in several cell-damaging models, such as glutamate and kainic acid-induced excitotoxicity insults in spinal neurons, 6 rotenone-induced degeneration of cells in the substantial nigra, 7 glutamate-induced excitotoxic effect in primary hippocampal cultures, 8 serum withdrawal-induced apoptosis in primary cultured cortical neurons, 9 glutamate induced in dopaminergic cell loss 10 and 1-methyl-4-phenyl-pyridinium þ -induced apoptosis in human SHSY5Y cells. 11 However, little work has been done in hypoxiceischemic conditions. Furthermore, the detailed mechanisms underlying the neuroprotective efficacy of ginsenoside Rg1 still await investigation.
The maintenance of Ca 2þ homeostasis is important for cell function and survival, conversely, intracellular calcium ([Ca 2þ ]i) overload is believed to be one of the first events triggered by brain ischemia. 12, 13 Nitric oxide (NO) is a ubiquitous messenger molecule that also acts as a neuronal messenger molecule in the central nervous system. NO has been demonstrated to be produced enzymatically in response to activation of N-methyl-D-aspartate (NMDA) receptors. 14 This activation results in an elevated influx of Ca 2þ ions into the postsynaptic structure, which in turn activates NOsynthase (NOS) under physiological conditions. 14e16 Prior studies have demonstrated that NOS mediates the ischemiainduced neuronal damage. 17 The present investigation was designed mainly to evaluate the role of Rg1 on Ca 2þ influx and the activity of neuronal NOS (nNOS) in experimental stroke models induced by oxygeneglucose deprivation (OGD).
Methods

Reagents
Ginsenoside Rg1 was isolated and purified at China Pharmaceutical University (Nanjing, China). Neuronal NOS detection kit was provided by Nanjing Jiancheng Bioengineering Institute (Nanjing, China). Poly-L-lysine, glutamine, trypsin, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra zolium bromide (MTT) were purchased from Sigma-Aldrich (St Louis, MO, USA). Fetal horse serum, Dulbecco's modified Eagle medium (DMEM), Neurobasal, and B27 were obtained from Invitrogen Gibco (Carlsbad, CA, USA). Fetal bovine serum was provided by Sijiqing Biological Engineering Institute (Hangzhou, China). Hoechst 33258 fluorescent dye kit was obtained from Beyotime Institute of Biotechnology (Jiangsu, China). All other chemicals were of the purest grade available from regular commercial sources.
Primary rat hippocampal cell culture
Protocols were in accordance with the International Guidelines for Animal Research and were approved by the Animal Care and Experimental Committee of Nanjing Medical University (Jiangsu, China). Hippocampi were aseptically dissected out from embryonic Day 18 SpragueeDawley rat embryos acquired from the Experimental Animal Center of Nanjing Medical University. Hippocampal neurons were dissociated from the tissues as previously described elsewhere. 18 After trituration and trypsinization, hippocampal cells were resuspended in DMEM supplemented with 10% fetal bovine serum, 10% horse serum, glutamine 100 mg/mL, and penicillin/streptomycin (100 U/mL and 100 mg/mL, respectively). The single-cell suspension was seeded in 35 mm petri dishes or 96-well plates (Corning Inc., Corning, NY, USA) coated with poly-L-lysine at a density of (2e5) Â 10 5 / mL. After 24 hours, cells were maintained in Neurobasal medium supplemented with 2% B27, penicillin/streptomycin (100 U/mL and 100 mg/mL, respectively) in a humidified atmosphere of 5% CO 2 at 37 C.
OGD model establishment
Primary hippocampal neuronal cultures were incubated in deoxygenated, glucose-free medium to mimic the interruption of the supply of oxygen and nutrients to the brain parenchyma. Hippocampal neurons were cultured in vitro for 8e10 days prior to being randomly divided into control group, model group (vehicle), ginsenoside Rg1 intervention group (low-, intermediate-, and high-dose). The number of cells in each group was counted in four 20Â fields, and all of them were equal (about 120e150 cells/20Â fields). Ginsenoside Rg1 of different concentrations (5mM, 20mM, and 60mM) was added to the culture medium 30 minutes prior to OGD. The culture medium was replaced by prewarmed DMEM with low glucose (1 g/L) in the model group and ginsenoside Rg1 intervention group, whereas the control group received high-glucose (4.5 g/L) DMEM. The cultures were then transferred to a hypoxia chamber containing gas mixture of equilibrated 95%N 2 /5%CO 2 for 2.5 hours at 37 C. OGD was terminated by placing the cultures back into the normoxic incubator with normal culture medium. Sham OGD cultures were exposed in normoxic conditions during the same period of time as the OGD cultures. Twenty-four hours after OGD procedures, neuron cultures were terminated to run tests.
[Ca 2þ ]i measurement using Fluo-3-AM-based microfluorimetry
To observe the possible influence of Rg1 on the elevated [Ca 2þ ]i induced by OGD, the fluorescence intensity was detected 24 hours after OGD. The procedures of OGD model establishment and Rg1 treatment have been described above. At 24 hours post-OGD, the existing maintenance medium was carefully discarded and the hippocampal cells were washed with PBS three times. For loading with Fluo-3-AM, the hippocampal cells were incubated without light for 30 minutes at 37 C with a final concentration of 10mM Fluo-3-AM. Once dye-loaded, the cells were washed thoroughly with the assay buffer to remove any unincorporated dye. The intensity of fluorescence was recorded with the excitation wavelength at 488 nm and emission wavelength at 525 nm using a Zeiss LSM-510 laser scanning confocal microscope (Carl Zeiss, Jena, Germany). The [Ca 2þ ]i was estimated from the fluorescence signal, accounting for the binding of calcium to the dye. All the fluorescence image data were collected and analyzed with the LSM510, version 2.3 software (Carl Zeiss).
Neuronal NOS determination
Hippocampal cells were collected when cell culture was terminated 24 hours after OGD as mentioned above. After being washed with PBS, hippocampal cells were lysed with cell lysis buffer, followed by which supernatant was discarded after centrifugation at 4 C, 16,000g for 10 minutes. The nNOS activity was measured by chemical colorimetry according to the manufacturer's instructions. There were no endothelial cells and inflammatory cells involved in the cultured hippocampal cells, suggesting that determined NOS activity was totally attributed to nNOS.
Cell viability assay
Cell viability was evaluated by the MTT assay, which is based on the reduction of MTT by the mitochondrial dehydrogenase of intact cells to form a purple formazan product as described previously. 19 In brief, at 24 hours post-OGD, 20 mL of MTT solution (5 mg/mL) was added to each well and the plates were incubated at 37 C for another 4 hours. The medium was then replaced by 100 mL DMSO and the amount of formed purple formazan dye was determined by measuring the absorbance value at a wavelength of 490 nm using a microplate reader (Bio-Rad Laboratories, Hercules, CA, USA). Each experiment was performed using six replicated wells for each group and carried out independently three times.
Fluorescence analysis of apoptosis
Hippocampal cells were stained with Hoechst 33258 according to the manufacturer's instructions for the Hoechst Staining Kit (Beyotime Institute of Biotechnology) to detect the characteristic features of apoptotic nuclei. The cultured hippocampal neurons were fixed in ice-cold 4% phosphate-buffered paraformaldehyde overnight and then incubated at room temperature with 1 g/mL Hoechst 33258 dye (Beyotime Institute of Biotechnology) for 5 minutes. Cells were analyzed under an inverted phase-contrast fluorescence microscope at 400Â magnification and counted by a blinded investigator from three independent experiments. The cultured hippocampal cells with fragmented DNA, condensed DNA, or normal DNA were counted. The ratio of apoptotic neurons to total neurons was calculated. In each experiment, 200 cells were examined in random fields from three culture wells for each condition to estimate the percentage of apoptotic hippocampal cells.
Statistical analysis
Results are expressed as mean AE standard error of the mean. Data were statistically evaluated by one-way analysis of variance (ANOVA) to determine differences among the groups. A probability level of p < 0.05 was accepted as statistically significant. All statistical analyses were performed with SPSS 11.5 (SPSS Inc., Chicago, IL, USA) software.
Results
Effect of ginsenoside Rg1 on OGD-induced [Ca 2þ ]i increase
After being stained with Fluo-3 AM, hippocampal neurons emitted fluorescence excited by an argon laser of 488 nm wavelength (Fig. 2) . The effect of ginsenoside Rg1 on [Ca 2þ ]i in hippocampal cells after OGD is shown in Fig. 3 ]i response.
Effect of ginsenoside Rg1 on OGD-induced nNOS activity increase
The nNOS activity of hippocampal cells in the OGD group was significantly elevated (p < 0.05) compared with that in the control group. Compared with the model group, the nNOS activity of the intermediate and high dose (20mM, 60mM, respectively) ginsenoside Rg1 intervention groups of decreased significantly (p < 0.05); however, the low-dose (5mM) ginsenoside Rg1 intervention group did not reach statistical significance compared with the model group. Pretreatment with a relatively high concentration (20mM, 60mM) of ginsenoside Rg1 inhibited OGD-induced elevated nNOS activity. However, pretreatment with a low concentration of ginsenoside Rg1 (5mM) did not significantly affect the OGDinduced elevated nNOS activity (Fig. 4) .
Effect of ginsenoside Rg1 against OGD-induced cytotoxicity
The possibility that ginsenoside Rg1 can have a direct protective effect on hippocampal neurons against ischemia/ reperfusion injury was detected by analyzing the effect of ginsenoside Rg1 on OGD-induced neuronal death by MTT assay. As shown in Fig. 5 , exposure of hippocampal neurons to 150 minutes of OGD induced significant cell death at 24 hours after reperfusion. The cell survival in the control group was standardized to 100%. Pretreatment with a relatively high concentration (20mM, 60mM) of ginsenoside Rg1 inhibited OGD-induced neuronal death with a significant elevation of neuronal survival rate (p < 0.05), whereas a low dose (5mM) of ginsenoside Rg1 slightly increased hippocampal neuronal viability compared with the model group, but did not reach statistical significance.
Effect of ginsenoside Rg1 on OGD-induced apoptosis
To better characterize the effects of ginsenoside Rg1 on OGD-induced neuronal cell death, Hoechst 33258 (Beyotime Fig. 2 . Representative microphotographs of hippocampal neurons that emitted fluorescence when excited by an argon laser of 488 nm wavelength after being stained with Fluo-3 AM (original magnification 400Â) by using a Zeiss LSM-510 laser scanning confocal microscope. ]i induced by OGD, Rg1 was added 30 minutes prior to the procedure of OGD, and the fluorescence intensity was detected 24 hours after OGD procedures. The data are means AE standard error of the mean from three independent experiments. Statistical significance was evaluated by one-way analysis of variance. p < 0.05 was regarded as statistically significant. * p < 0.05 versus model group (OGD).
Institute of Biotechnology) was added to cultured cells after OGD insult in the presence or absence of ginsenoside Rg1. Exposure to OGD also resulted in apoptotic death of hippocampal neurons, as revealed by the appearance of condensed (bright blue) nuclei in Hoechst-stained cultures (Fig. 6A) . A total of 200 cells spotted on glass slides from randomly chosen microscopic fields were examined and counted by fluorescence microscopy, and the percentage of cells exhibiting apoptotic degeneration relative to the total number was calculated as the apoptotic index from three independent experiments. Through cell counting, it was determined that 46.94 AE 3.14% of cultured neurons were apoptotic at 24 hours post-OGD, as compared to 5.24 AE 0.92% of neurons apoptotic in the total population of the control group. However, treatment with ginsenoside Rg1 (5mM, 20mM, 60mM) significantly decreased OGD-induced apoptotic cell death, with the percentage of apoptotic neurons being 44.24 AE 4.27%, 36.24 AE 2.75%, and 34.32 AE 2.18%, respectively. Pretreatment with relatively high concentrations (20mM, 60mM) of ginsenoside Rg1 inhibited OGD-induced elevated hippocampal neuronal apoptotic index (p < 0.05), whereas a low dose (5mM) of ginsenoside Rg1 slightly decreased OGD-induced hippocampal neuronal apoptotic index, but did not reach statistical significance (Fig. 6 ).
Discussion
In the present study, we investigated whether treatment of primary cultures of rat hippocampal cells with ginsenoside Rg1 was able to prevent neurotoxicity resulting from OGD. The present data in our cell-damaging models highlight that ginsenoside Rg1, one of the active ginsenosides, exhibited protective effects against neuronal damage induced by hypoxiceischemic insults. We found that Rg1 improved neuronal viability and ameliorated apoptotic rate in cultured hippocampal neurons after OGD. Moreover, with Rg1 treatment, elevated intracellular Ca 2þ concentrations and nNOS activity induced by OGD were markedly inhibited, suggesting that the neuroprotective activities of Rg1 were mediated by blocking calcium over-influx into neuronal cells and attenuating nNOS activity. These results suggest that Rg1 could prove to be a novel therapeutic candidate for the treatment of ischemic cerebral stroke.
Ginsenosides are amphiphilic and have the ability to intercalate into the plasma membrane, which leads to alterations in membrane fluidity and affects membrane function. 3 The effects of ginsenosides may be initiated at the plasma membrane by interacting with multireceptor systems, 20 as well as via intracellular protein binding to produce genomic effects. Accumulated evidence has been found to demonstrate the neuroprotective effects of ginsenosides. Ginsenosides may rescue neuronal cells by increasing cell survival, extending neurite growth, and protecting neurons from death either in vivo or in vitro. 10, 21, 22 Ginsenosides have been exhibited to act as antioxidants, or scavengers for free radicals, by increasing the activity of superoxide dismutase and inhibiting lipid peroxidation. 23 In addition, ginsenosides upregulate nerve growth factor expression, which in turn promotes neuron survival. 24 Furthermore, ginsenosides could protect cortical neurons from glutamate insults by blocking Ca 2þ influx through glutamate receptors. 25 Thus, Rg1, a single ginsenoside, may also exhibit diverse functions by interacting with multireceptor systems. 3 Studies have demonstrated that Rg1 is able to increase dopamine content in the striatum. 26 Much work has been done to find Rg1 to be protective in some celldamaging models in recent years. Liao et al 6 observed that Rg1 could protect spinal neurons from excitotoxicity induced by glutamate and kainic acid, as well as oxidative stress induced by H 2 O 2 in a dose-dependent way. In a glutamate Fig. 4 . Effect of ginsenoside Rg1 on oxygeneglucose deprivation (OGD)-induced neuronal nitric oxide synthase (nNOS) activity increase. The neuronal NOS activity was measured by chemical colorimetry according to the manufacturer's instructions in the assay kits. The data are mean AE standard error of the mean from three independent experiments. Statistical significance was evaluated by one-way analysis of variance. p < 0.05 was regarded as statistically significant. * p < 0.05 versus model group (OGD). ** p < 0.05 versus control group. Fig. 5 . Effect of ginsenoside Rg1 on oxygeneglucose deprivation (OGD)-induced cytotoxicity. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was conducted to evaluate the protective efficacy of ginsenoside Rg1 on hippocampal neurons against ischemia/reperfusion injury. The data are mean AE standard error of the mean shown as percentages of the viability of the control group from three independent experiments. Each experiment was performed using six replicated wells for each group. Statistical significance was evaluated by one-way analysis of variance. p < 0.05 was regarded as statistically significant. * p < 0.05 versus model group (OGD). excitotoxic model, Liu and Zhang 8 found that Rg1 increased the cell viability and reduced the LDH release of cortical neurons. Li et al 9 reported that Rg1 inhibited the apoptosis of the cultured cortical neurons with serum withdrawal. Leung et al 7 showed that Rg1 exerted a protective effect on nigral neurons against rotenone toxicity. Radad et al 10 documented that ginsenoside Rg1 had a partial neurotrophic and neuroprotective effect in dopaminergic cell culture stressed with glutamate.
The results of our present study are consistent with most of these findings. Physiological Ca 2þ signals are indispensable for cell function and survival, whereas Ca 2þ overload or perturbations of intracellular Ca 2þ compartmentalization can activate or promote mechanisms leading to cell death. Alterations of intracellular Ca 2þ storage can integrate with death signals to promote processing of cellular components and death by apoptosis or necrosis. Furthermore, Ca 2þ can directly activate catabolic enzymes such as proteases, phospholipases, and nucleases that directly cause cell demise. 13 In neurons, the Na þ /Ca 2þ exchanger and ATP-driven plasma membrane Ca 2þ pump are involved in the plasma membrane Ca 2þ extrusion systems to regulate the intracellular Ca 2þ content so that Ca 2þ fluctuations are kept within physiological level. 27 It is generally accepted that calcium overload is involved in ischemic brain injury. 12, 13 In pathological conditions, including cerebral ischemia, a massive glutamate release leads to glutamate neurotoxicity. The neurotoxicity is mainly due to activation of NMDA receptors, which cause excessive elevation of [Ca 2þ ]i and subsequent neuronal cell death. 28 Elevation of [Ca 2þ ]i following NMDA receptor activation also stimulates NOS.
NO is generated from the amino acid L-arginine by NOSs. Mammals contain three NOS isoforms: nNOS, inducible NOS, and endothelial NOS. 29 NO is a messenger molecule that has numerous molecular targets. Neuronal NOS is expressed in specific neurons of the brain, the activity of which is regulated by Ca 2þ and calmodulin. Neuronal NOS has been implicated in modulating physiological functions, such as learning, memory, and neurogenesis. Abnormal NO signaling is very likely to be involved in a variety of neurodegenerative pathologies, including excitotoxicity following stroke. 30 Hyperactive nNOS, stimulated by massive Ca 2þ influx into neuronal cells, has been implicated in NMDA receptor-mediated neuronal death in cerebrovascular stroke. Under these conditions, NO contributes to excitotoxicity, probably via peroxynitrite activation of poly adenosine diphosphate-ribose polymerase and mitochondrial permeability transition. High levels of NO can also exert energy depletion, owing to inhibition of mitochondrial respiration and glycolysis. 31, 32 In the present study, cultured hippocampal neurons were subjected to OGD to mimic the cerebral ischemia injury. After OGD insult, intracellular free Ca 2þ concentration of hippocampal neurons markedly increased, probably via activating ionotropic and metabotropic glutamate receptors. We showed that Rg1 inhibits the increase of Ca 2þ influx in hippocampal neurons subjected to OGD. Recently, Zhang et al 33 reported that inhibition of Rg1 on NMDA receptors and L-type voltagedependent Ca 2þ channels may be potentially involved. In addition, nNOS activity resulting from OGD was significantly elevated, which was attributed to stimulation of massive Ca 2þ influx into hippocampal neurons. 17 The elevated nNOS activity was markedly inhibited by Rg1 treatment. We may hypothesize that it is partially attributable to inhibition of Ca 2þ influx mediated by NMDA receptors and L-type voltagedependent Ca 2þ channels. However, whether other mechanisms are attributable to this phenomenon remain to be elucidated. Hence, ginsenoside Rg1 attenuates OGD-induced neuronal cell death by inhibition of both [Ca 2þ ]i increase and Ca 2þ -dependent nNOS activity. It is suggested that the neuroprotective effect of Rg1 is probably mediated by the inhibition of Ca 2þ influx to maintain the Ca 2þ homeostasis and keep an appropriate nNOS activity. Given that the overall pharmacology of ginsenosides is complex, it is likely that other factors in addition to Ca 2þ and nNOS activity stabilizing effects may also contribute to the actions of ginsenoside Rg1. Therefore, more studies on pharmacological mechanisms of neuroprotective actions and toxicity of ginsenoside Rg1 are required.
In conclusion, ginsenoside Rg1 exerted a neuroprotective effect on OGD hippocampal neurons, which was probably mediated by the inhibition of Ca 2þ influx and nNOS activity, suggesting that, at least in part, the protective actions resulted from inhibition of Ca 2þ signaling. As a result, neuronal viability was elevated and apoptotic neurons diminished in number. However, the molecular mechanisms that underlie the protective actions of ginsenosides are not fully understood. Even so, ginsenoside Rg1 may serve as a potential therapeutic agent for cerebral ischemia injury, and further in vivo studies on stroke should be encouraged to confirm the potential neuroprotective effects of Rg1.
